New Clozapine Data Suggest FDA Should Ease Restrictions
The risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
Medscape Medical News
source https://www.medscape.com/viewarticle/new-clozapine-data-suggest-fda-should-ease-onerous-2024a100096l?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/new-clozapine-data-suggest-fda-should-ease-onerous-2024a100096l?src=rss
Comments
Post a Comment